Femtech Startup Ovum AI Secures $4 Mn Seed Round

Femtech startup Ovum AI has secured $4 million in seed funding to scale globally, led by Admiralty Capital Group. 

The raise, which tripled the company's valuation to $18 million, also attracted participation from investors including Antler, Brisbane Angels, Giant Leap, and LaunchVic’s Alice Anderson Fund.

The Melbourne-based startup plans to use the capital to expand its workforce and broaden its health data assets to advance AI applications in women’s healthcare.

Founded in 2025 by Dr Ariella Heffernan Marks, Ovum AI helps users track symptoms, menstrual cycles, lifestyle factors, and medical records within a single longitudinal health profile.

Building a data-driven women’s health platform

At the core of the platform is the "Ovum Brain," an AI engine that analyzes health data to identify patterns, generate personalized insights, and create appointment-ready summaries and questions.

The startup claims the technology helps women better manage their health and make more informed healthcare decisions.

It has launched clinical trials at St. George Hospital and the Royal Hospital.

Partnership and users

Backed by partnerships with organisations including Medibank, Sweat, Menopause Friendly Australia, Fernwood Fitness, and Red Cross Lifeblood, Ovum has been growing at 30% month-on-month.

The startup has surpassed 20,000 app downloads and facilitated more than 107,000 AI-driven health conversations. It has also captured 57,000 health data insights from women across a broad age range. It generates revenue through subscriptions and enterprise partnerships.  

The organisation previously raised $1.7 million in a pre-seed round in February 2025, before launching its platform in the same year.

Source: Capital Brief

Follow Inspirepreneur Magazine for daily global business news.